Table 6.
Probes which are differentially methylated in RA, SLE and MS.
| CpG | Chr | Gene | RA (n = 65 cases) Δmeth | SLE (n = 47 cases) Δmeth | MS (n = 24 cases) Δmeth |
|---|---|---|---|---|---|
| cg18972751 | 1 | CD1C | 5.7 | 3.4 | 5.3 |
| cg09327855 | 1 | NID1 | 1.3 | 1.1 | 10.2 |
| cg03055617 | 3 | TNFSF10 | −6.9 | −5.9 | |
| cg06613783 | 10 | SKIDA1 | 2.7 | 1.6 | |
| cg07285641 | 13 | DHRS12 | 1.7 | 1 | |
| cg01619562 | 14 | ITPK1 | 3.4 | 1.03 | 3.8 |
| cg01810713 | 16 | IRF8 | 3.1 | 10.1 | |
| cg04033022 | 16 | ACSF3 | 2.6 | 0.12 | 14.8 |
| cg00253346 | 22 | TNFRSF13C | 2 | 1.4 | 8.1 |
| cg08271031 | 22 | PARVG | 2.2 | 3 |
Bold = differential methylation in all three diseases. Based on ref.36. Julia A. et al. Hum Mol Genet. 2017; 26(14):2803-11.